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Introduction
In recent years modification of biomaterial surfaces has been studied through various methods to render them bioactive. Surface coatings based on the layer-by-layer (LbL) method have been reported as a versatile and easy way of building polymeric surface coatings in environmentally friendly conditions, mostly from aqueous solutions. 1 The layer-by-layer method is based on the electrostatic attraction between polyanions and polycations, the advantage of this method is the possibility of preparing ultra-thin and well-defined films. 2, 3 The spontaneous sequential adsorption of dissolved cationic and anionic polyelectrolytes on the substrate leads to the formation of ordered multilayer assemblies on the solid substrate surface. 4 These multilayers are widely used in biotechnology as controlled release systems, cell growth surfaces, anti-adhesive coatings and stimuli responsive surfaces. As the system is composed of charged molecules, it is ideal to control the release of charged bioactive agents such as cytokines and the strength of electrostatic interactions between the film and the cytokine should be a key parameter to determine the rate of release. 5, 6 Biological properties and physicochemical characteristics of polyelectrolyte multilayer film coated device surfaces have been explored in order to get better properties between the implant and tissue interface. 7 The polyelectrolyte multilayer films PLL/HA ((poly(L-lysine) associated with hyaluronic acid) have been extensively studied. Furthermore, it has been successfully used for the release of growth factors and drugs. [8] [9] [10] [11] Degradation of these films via dissolution is an obstacle for achieving long-term release of cytokines, which can be improved by structures crosslinking. 12, 13 Moreover, it is known that crosslinking these PLL/HA films strongly increase viability of cells growing on the films, mainly due to an increase of Young modulus. 14, 15 For example, the chemical crosslinking with a mixture of 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide/N-hydroxysulfosuccinimide (EDC/NHS) is widely used for several polyelectrolyte multilayers (PEMs), typically, PLL/HA, PLL/polyglutamic acid (PLL/PGA), and chitosan/HA. [16] [17] [18] The EDC/NHS crosslinking involves a reaction between carboxylic groups of HA and amine groups of PLL. However, to achieve the crosslinking reaction a long incubation time is required (at least 12 hours) and also some extensive rising steps after it, in order to eliminate excess products that can be toxic. 19 Hyaluronic acid (HA) is a glycosaminoglycan mainly localized in extracellular matrix. It plays an important role in lubrication, cell differentiation, angiogenesis, anti-inflammatory response and cell growth. Since HA plays a major role in all wound healing steps, its exogenous application presents the potential to get a faster healing. The presence of the functional groups such as alcohols and carboxylic acids along the backbone of HA allows the introduction of functional domains on it. 20, 21 The addition of functional groups provides the possibility to adjust physical parameters of the films formed with the HA and consequently the cell response to these films can be also influenced. HA is one of the biodegradable polysaccharides that has been broadly studied as a protein carrier. To date, owing to its potential as a drug delivery platform HA has been used as carrier for anti-tumoral and anti-inflammatory drugs. [22] [23] [24] [25] Focusing on protein delivery, Mero and colleagues developed a HA-aldehyde derivative as an appropriate platform for the N-terminal site selective conjugation. To achieve that, short pendant chains of 4-aminobutyraldehyde were introduced on the HA backbone. 26 The main advantage of the aldehyde moieties attached on the polymeric chain is that under physiological conditions they can react with a wide range of amino compounds. Another possible type of oxidized HA is the HA derivative with aldehyde groups in position 6 of the N-acetyl-D-glucosamine part. 27, 28 Unlike materials prepared by standard oxidation of HA with sodium hypochlorite, this polymer consists of intact saccharide rings plausibly mimicking the structure of the native HA backbone. 26 Its capability to react with lysine was also successfully proved 29 which indicates that this polymer is promising for the interaction with polylysine in a multilayer system. Thus, the polyelectrolyte multilayer films formed by self crosslinking of PLL and HA-Aldehyde without 30 One of the key components of inflammation and subsequent events are macrophages. They are cells with considerable phenotypic plasticity which are generally described within two extreme conditions. The pro-inflammatory M1 macrophage is associated with classic signs of inflammation whereas, the pro-healing M2 macrophage stimulates tissue repair, immunoregulation and tissue remodeling. 31 In wound healing process, at early stages a pro-inflammatory M1 phenotype is dominant, whereas in later stages this is shifted towards a pro-healing M2 phenotype. It is known that M1 phenotype macrophages initiate angiogenesis, whereas M2 macrophages stabilizes the growing vasculature. The success or failure of a material device is strongly dependent on the inflammatory response. [31] [32] [33] Thus, surface coatings which can provide long term release of M2 inducing cytokines would help in the resolution of inflammation around the implanted materials and can contribute to the faster healing and implant integration (more details can be found in the Supporting Information).
The Layer-by-Layer technique is a well-known method to obtain bioactive coatings with multiple functionalities. 34 The obtained multilayers are widely used as controlled-release drug systems without changing their biological function within the coating. [35] [36] [37] [38] Sukhishvili et al. have recently reported a coating with a "self-defense" behavior that promotes the release of different dose of antibiotic in function of the decrease of the pH around the surface due to the presence of bacteria. 39 Here, we report, for the first time, polyelectrolyte multilayers films made of poly-(Llysine) and hyaluroanan-aldehyde (PLL/HA-Ald) derivative, which possess the main advantage to form stable structures through an auto-crosslinking mechanism. Their physicochemical properties could enable the release of M2-promoting cytokines such as interleukin-4 (IL-4), to promote differentiation of incomming macrophages in the M2 phenotype (anti-inflammatory and remodeling promotion) (Scheme 2).
Scheme 2.
Macrophage differentiation into M2 type is promoted by the implant surface and presence of IL-4 release system.
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Monitoring of the build-up process by quartz crystal microbalance (QCM)
The build-up process of the multilayer were examined in situ by a QCM (Q-Sense 401 flow module QCM-D E1, Q-Sense, Västra Frölunda, Sweden). The molecule adsorption induces the quartz crystal, changing the resonance frequency f of it. The quartz crystal was excited at its fundamental frequency of 5 MHz and its third harmonic frequency (denoted by ν = 3) at 15 MHz was monitored. During each step of molecule adsorption the changes in the resonance frequency, (f) were obtained. The crystal used for these experiments is coated with a SiO 2 film (100 nm thick -QSX 303 crystal from Q-Sense). In first approximation, the diminution of the normalized frequency shift, -f/ν, is be related with a growth of the adsorbed mass on the crystal.
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Determination of film thickness
The thickness of the films were obtained by confocal laser analysis. For that, it was used a Zeiss confocal microscope (LSM, 710) using a 40x (Zeiss Achroplan) objective. 
where δ is the indentation depth, ν the Poisson coefficient, R is the colloids radius and h the sample thickness. The Dimitriadis correction for finite thickness is defined by χ parameter:
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All the curves were analyzed by mean of an automatic Matlab algorithm described elsewhere. MicroBeads and LS columns, Miltenyi Biotec) as we have previously described. 45 This method [1] [2]
routinely yielded 95% pure monocytes as determined by flow cytometric analysis of CD14 expression.
Purified monocytes were cultured at 1 x 10 6 cells / mL / well in RPMI-1640 supplemented with 10% fetal bovine serum (FBS), 2 mM L-glutamine, 100 U.mL -1 penicillin, and 100 µg.mL -1 streptomycin (all from Sigma-Aldrich) in 12-well tissue culture-treated plates containing the coated films. Samples and controls were incubated at 37°C, 5% CO 2 for 1, 3 and 6 days. Scheme 4 shows the time line of the experiments and the readouts made. 
Phase contrast microscopy
Phase contrast images were captured using an Olympus CDX41 microscope (Olympus Corporation, Japan) with an Infinity 2 camera and Infinity Analyze software.
Blue assay
The AlamarBlue assay kit (Thermo Fisher Scientific, USA) was used to determine the cell viability as per the manufacturer's instructions. Controls were monocytes plated in 12-well tissue culture-treated plates in the same medium in the absence of any cytokines (TC control).
Cytokine analysis
Supernatants were collected and assayed for the cytokines TNF-α, IL-12, IL-1β, CCL18 and IL-1RA by ELISA as per the manufacturer's instructions (Table 1) . 
Results and Discussion
PLL/HA and PLL/HA-Aldehyde polyelectrolyte multilayer film characterizations
The build-up process of the multilayered films was monitored in situ by quartz crystal microbalance-dissipation. In first approximation, decreases in the normalized resonance frequency -f/ν can be associated with a variation of the mass adsorbed on the crystal. The evolution of -f/ν with the number of deposited layers are exponential for both PLL/HA and PLL/HA-Ald, (Figure 1 ). However in the case of covalent multilayers, the mass adsorbed for a given number of layers appears slightly higher than for non-covalent multilayers. Many parameters could be at the origin of the difference in these growth like molecular weight of HA (300 kDa for HA and 436 kDa for HA-Ald) or the covalent binding of HA-Ald to PLL. This may be attributed to the diffusion of mobile PLL-FITC chains in and out of the film due to interlayer mixing of HA and PLL-FITC. This also suggests that despite formation of covalent bonding due to the presence of HA-Ald in (PLL/HA-Ald) 24 multilayers, some PLL-FITC chains are able to diffuse at least during the build up process. Then, FRAP experiments (fluorescence recovery after photobleaching) were performed and showed that after bleaching a circular area in the PLL/HA film, the green fluorescence corresponding to PLL-FITC chains was almost (80%) totally recovered after 50 minutes ( Figure   3 ). This found recovery was due to lateral mobility of the PLL chains within the film. It was previously demonstrated that about 70% of PLL chains are mobile in a non-cross-linked PLL/HA film. 47 In comparison, when PLL/HA-Ald was used, the recovery of fluorescence was slower. This indicates that mobility of PLL-FITC in PLL/HA-Ald is lower than that on PLL/HA, and it could suggest that some PLL-FITC chains are crosslinked and could not diffuse any more.
From Figure 3 , we can conclude that almost 40% of the fluorescence is recovered in PLL/HAAld and thus about 60% of PLL chains are immobile. Finally FRAP experiments confirm that HA-Ald is able to crosslink the film. In comparison with the more conventional method using EDC, HA-Ald is a self-crosslinking method that do not need any additional steps with chemicals after the film buildup.
PLL/HA films are known to have the capacity to be loaded with a high amount of proteins like Human Serum Albumin 42 or drugs like paclitaxel. 48 However little is known on this aspect for covalent multilayers and nothing is known for HA-Ald. In order to study the release behavior of our multilayer films, the FITC-labeled bovine serum albumin (BSA-FITC) and interleukin 4 (IL-4) were loaded on the top of the films. BSA is used as a model protein and IL-4 is the cytokine selected for our immunomodulation studies described later. BSA-FITC (100 µL) was deposited for 1h at a concentration of 1 mg.mL -1 on top of either PLL/HA or PLL/HA-Ald films. After rinsing steps, it was observed by confocal analysis that there is no difference in amounts of BSA- Figure S3 ). For non-crosslinked PLL/HA films, the release of BSA-FITC is almost similar when PBS or media containing serum have been used as supernantant :
0.08 mg.mL -1 is released after 24h in both cases. However for crosslinked PLL/HA-Ald films the amount of BSA-FITC released after 24h is about 3 times higher in complete medium compared to PBS. Finally the slower release and thus the higher affinity of BSA to PLL/HA-Ald films can be attributed to higher hydrophobicity in these films because covalent PLL/HA interaction could be more tight and could release more water.
Then we focused our study on the release of interleukin 4 (IL-4), a key cytokine in type 2 immunity, which is also essential for anti-helminth protection, wound healing, and allergy. 49 This protein with a molecular weight of 15 kDa is positively charged at pH 7.4 (pI=9.17). From QCM experiments, we monitored a loading rate of IL-4 corresponding to an increase of normalized frequency value of about 75 Hz for (PLL/HA) 6 and (PLL/HA-Ald) 6 films (data not shown), which means that the same adsorbed amount of the cytokines was adsorbed for both films.
Unlike BSA, IL-4 released at the first 48 hours is significantly higher for PLL/HA-Ald films compared to PLL/HA films (t-test, P ≤0.042, n=3), (Figure 4b ). Finally this means that PLL/HA-they maintain the same ability to release IL-4. 
Monocyte phenotype and behavior on PLL/HA and PLL/HA-Ald multilayers
In order to determine, whether the release of IL-4 can control macrophage phenotype on PLL/HA films, primary monocytes were seeded on the films in the presence and absence of IL-4. Finally, PLL/HA-Ald films could have applications where anti-inflammatory / pro-wound healing macrophage populations would be beneficial in improving the rate and quality of implant integration, protection of biomedical devices such as electrodes from adverse immune reactions.
Conclusions
In summary, the results show that polyelectrolyte multilayers made of PLL and HA-aldehyde derivative can be successfully built. The introduction of the bioactive molecules, interleukin-4, can be used for functionalization these films. Moreover, drug release behavior could be to permanent titanium implants such as dental, orthopaedic replacement systems or in neuroprosthetic devices in the brain. We plan to use these coatings also for improvement of integration of recently developed artificial larynx system that is clinical trial stage.
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